Skip to Content

Mergers & Acquisitions

Strategic Advisory

Corporate Valuations

Industry Expertise

Mergers & Acquisitions

Strategic Advisory

Corporate Valuations

Industry Expertise

Folder: Services

Mergers & Acquisitions

Strategic Advisory

Corporate Valuations

Industry Expertise

ImaRx Pharmaceutical, Inc.

Healthcare & Life SciencesCapital Raise

Jun 1

Written by Emily Dyer-Wolfe

ImaRx Pharmaceutical, Inc.

Sale of ImaRx Pharmaceuticals, Inc. to DuPont for $44 Million in DuPont Common Stock. Sale included the rights to the lipid based imaging patent for cardiovascular pharmaceuticals only on a world-wide basis.

Emily Dyer-Wolfe

International Genomics Consortium

ImaRx Pharmaceutical, Inc.

Copyright 2021. Aaron Capital, Inc. All Rights Reserved